Breaking News

Eurofarma Implements Körber’s PAS-X Manufacturing Execution System

Enables real-time data access, full traceability, and enhanced regulatory compliance.

Eurofarma Laboratórios has transitioned all of its manufacturing operations at the main production facility in Itapevi, São Paulo to Körber’s PAS-X Manufacturing Execution System—becoming the first national company in Brazil to do so. The implementation paves the way to operational excellence, enabling real-time data access, full traceability, and enhanced regulatory compliance.

At the Itapevi site, Eurofarma manufactures a wide range of products, including generics, oncology medicines, OTC drugs, and veterinary products – all of which were previously produced through manual processes. These numerous manual tasks, supported by thousands of paper documents, needed to be replaced with digital workflows.

Today, over 200 workstations are using Electronic Batch Recording (EBR), covering the entire process from warehouse distribution to final packaging. This spans five buildings and multiple production types. The implementation also includes digital equipment setup, cleaning processes, and electronic logbooks.

“We’re celebrating a major milestone in our digital transformation journey with the successful implementation of PAS-X MES at our facility,” said Allan Santiago, Director of Global Quality at Eurofarma. “This achievement marks a new era of operational excellence, enabling real-time data access, full traceability, and enhanced regulatory compliance. By replacing manual processes with digital workflows, we’ve significantly reduced errors and improved efficiency. For the Quality team, this means faster, data-driven decisions and stronger audit readiness.”

“We now operate a fully digitalized factory capable of producing thousands of batches per month, across various forms and presentations, in a harmonized and transparent way,” added Marilene Narciso, Digital Project Manager at Eurofarma. “With PAS-X MES, we have a robust tool that enables Eurofarma to reach new levels of maturity, integrating elements of Industry 4.0 and Artificial Intelligence as we move forward.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters